Gatifloxacin Ophthalmic

283 interactions 389 cited references

Also sold as: Zymar® Zymaxid Zymaxid®

About Gatifloxacin Ophthalmic

Gatifloxacin ophthalmic solution is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids) in adults and children 1 year of age and older. Gatifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the… Read the full Gatifloxacin Ophthalmic drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dronedarone Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir

12 Contraindicated 254 Major 17 Moderate

All (283) Contraindicated (12) Major (254) Moderate (17)

Major

Gatifloxacin Ophthalmic Efavirenz An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Encorafenib Braftovi Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Ertugliflozin Steglatro Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Erythromycin Erythrocin Stearate Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Escitalopram Lexapro An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Ethopropazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Etrasimod Velsipity Increased risk of transient reduction in heart rate, AV conduction, QT interval prolongation and an increased risk of torsade de p... Details Gatifloxacin Ophthalmic Exenatide Bydureon Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Fexinidazole An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Fingolimod Gilenya Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Flecainide Tambocor® An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Fluconazole Diflucan An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Fludrocortisone An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Fluocortolone An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Fluoxetine RECONCILE An increased risk of QT interval prolongation and an increased risk of torsades de pointes Details Gatifloxacin Ophthalmic Fluphenazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Formoterol Perforomist Increased risk of QT interval prolongation and an increased risk of cardiovascular adverse effects Details Gatifloxacin Ophthalmic Foscarnet Foscavir Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Fosfomycin Contepo An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Fosphenytoin Cerebyx An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Fostemsavir Rukobia Increased risk of torsade de pointes Details Gatifloxacin Ophthalmic Gemifloxacin Factive An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Gepirone Exxua An increased risk of QT interval prolongation and cardiac arrhythmias Details Gatifloxacin Ophthalmic Gepotidacin Blujepa An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Givinostat Duvyzat Increased risk of QT interval prolongation and torsade de pointes Details Gatifloxacin Ophthalmic Glasdegib Daurismo Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Glimepiride Amaryl Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Glipizide Glucotrol Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Glyburide DiaBeta® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Goserelin Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Granisetron Increased risk of QT interval prolongation and torsade de pointes Details Gatifloxacin Ophthalmic Haloperidol An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Histrelin Supprelin Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Hydrocortisone Ala-Cort An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Hydroxychloroquine Plaquenil An increased risk of seizures and an increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Hydroxyzine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Ibutilide Corvert An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Iloperidone Fanapt Increased risk of QT interval prolongation and torsade de pointes Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.